English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
TürkçeHere's What Key Metrics Tell Us About Beauty Health (SKIN) Q3 Earnings
For the quarter ended September 2025, The Beauty Health Company (SKIN) reported revenue of $70.7 million, down 10.3% over the same period last year. EPS came in at -$0.09, compared to -$0.15 in the year-ago quarter.
The reported revenue represents a surprise of +2.84% over the Zacks Consensus Estimate of $68.75 million. With the consensus EPS estimate being -$0.08, the EPS surprise was -12.5%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Beauty Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Geographic Revenue- Americas: $48.3 million versus $46.45 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -6.9% change. Geographic Revenue- EMEA: $16.1 million versus the two-analyst average estimate of $15.94 million. The reported number represents a year-over-year change of 0%. Geographic Revenue- Asia Pacific: $6.3 million versus $6 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -41.7% change. Delivery Systems Net Sales: $20.8 million versus $17.03 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -24.6% change. Consumables Net Sales: $49.8 million versus $51.36 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2.7% change.View all Key Company Metrics for Beauty Health here>>>
Shares of Beauty Health have returned -13.5% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Beauty Health Company (SKIN): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).